Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Porphyrias

imatinib mesylate has been researched along with Porphyrias in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capusan, TM; de Argila, D; Herrero-Moyano, M; Martinez-Mera, C; Steegmann Olmedillas, JL; Urquía Renke, A1
Bousema, MT; Hayes, DP; Kardaun, SH; Kramer, MH; Timmer-de Mik, L1

Other Studies

2 other study(ies) available for imatinib mesylate and Porphyrias

ArticleYear
Imatinib-induced pseudoporphyria.
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:4

    Topics: Antineoplastic Agents; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Porphyrias; Skin

2018
Imatinib-induced pseudoporphyria.
    Clinical and experimental dermatology, 2009, Volume: 34, Issue:6

    Topics: Adult; Antineoplastic Agents; Benzamides; Cytarabine; Drug Eruptions; Drug Therapy, Combination; Humans; Imatinib Mesylate; Leukemia, Myeloid; Male; Piperazines; Porphyrias; Pyrimidines

2009